期刊文献+

白藜芦醇/siRNA胶束复合物的载药和释药性能研究

Study on drug loading and drug release properties of Resveratrol /siRNA micellar polyplexes
下载PDF
导出
摘要 目的研究pH和还原性双响应白藜芦醇/siRNA胶束复合物(MCpH/Redox@Res-siRNA)的载药和释药性能。方法采用紫外分光光度法和荧光分光光度法分别建立白藜芦醇(Resveratrol,Res)和FAM-siRNA体外分析方法,超速离心法和超滤离心法测定MCpH/Redox@Res-siRNA中药物的包封率(Encapsulation Efficiency,EE%)和载药量(Drug Loading,DL%),透析法测定MCpH/Redox@RessiRNA中药物的释放性能。结果Res和FAM-siRNA的体外分析方法均符合方法学要求;MCpH/Redox@Res-siRNA中Res的EE%为(92.2±1.74)%、DL%为(9.72±1.63)%,FAM-siRNA的EE%为(94.5±1.42)%;MCpH/Redox@Res-siRNA中Res释放具有pH敏感性,siRNA的释放呈现pH和还原环境依赖性,在pH 5.5和还原性环境中,Res和FAM-siRNA释放较为迅速和完全。结论MCpH/Redox@Res-siRNA具有较好的Res和siRNA载药性能和释放性能。 Objective To study the drug loading and drug release properties of pH and reducing double-responsive Resveratrol/siRNA micellar polyplexes(MCpH/Redox@Res-siRNA).Methods UV spectrophotometry and fluorescence spectrophotometry were established for Resveratrol(Res)and FAM-siRNA in vitro respectively.Encapsulation Efficiency(EE%)and Drug Loading(DL%)of Res and FAM-siRNA in MCpH/Redox@Res-siRNA were determined by ultrafiltration centrifugal method and ultrafiltration centrifugal method.The drug release properties in MCpH/Redox@Res-siRNA was detected by dialysis.Results The EE%of Res and DL were(92.2±1.74)%,(9.72±1.63)%in MCpH/Redox@Res-siRNA.The EE%of FAM-siRNA were(94.5±1.42)%.The release of Res in MCpH/Redox@Res-siRNA was pH-responsive,and the release of siRNA is pH and reducing environment dependent.In pH5.5 and reducing environment,the release of Res and FAM-siRNA is rapid and complete.Conclusion MCpH/Redox@Res-siRNA have good Res and siRNA delivery and release properties.
作者 贾莉 苗方 张卫敏 安芸 董晓辉 马兰 JIA Li;MIAO Fang;ZHANG Weimin;AN Yun;DONG Xiaohui;MA Lan(Heze Medical College,Heze 274000,Shandong)
出处 《菏泽医学专科学校学报》 2023年第2期1-4,共4页 Journal of Heze Medical College
基金 山东省中医药科技项目(2021M204)。
关键词 胶束复合物 载药性能 释药性能 Micellar polyplexes Drug load property Drug release property
  • 相关文献

参考文献7

二级参考文献44

  • 1Yunwei Guo,Xiaoying Zhang,Zhiyun Zhao,Hongyun Lu,Bilun Ke,Xin Ye,Bin Wu,Jianping Ye.NF-κB/HDAC1/SREBP1c pathway mediates the inflammation signal in progression of hepatic steatosis[J].Acta Pharmaceutica Sinica B,2020,10(5):825-836. 被引量:10
  • 2杨红美,陈波,曾建国,缪建荣.HPLC同时测定虎杖及其提取物中4种有效成分的含量[J].中国中药杂志,2006,31(3):202-205. 被引量:23
  • 3霍美蓉,周建平,魏彦,吕霖.紫杉醇壳聚糖聚合物胶束的制备及表面电荷对其在小鼠体内组织分布的影响[J].药学学报,2006,41(9):867-872. 被引量:20
  • 4YANCOPOULOS G D, KLAGSBRUN M, FOLKMAN J. Vasculogenesis, angiogenesis, and growth factors: Ephrins enter the fray at the border [J]. Cell, 1998, 93(5): 661-664.
  • 5FOLKMAN J. Tumor angiogenesis: Therapeutic implications [J]. New Eng J Med, 1971, 285(21): 1182-1186.
  • 6FOLKMAN J. Tumor angiogenesis [J]. Adv Cancer Res, 1985, 43:175-203.
  • 7BAI X, CERIMELE F, USHIO-FUKAI M, et al. Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo[J]. J Biol Chem, 2003, 278(37): 35501-35507.
  • 8REYNOLDS A, LEAKE D, BOESE Q, et al. Rational siRNA design for RNA interference [J]. Nat Bio, 2004, 22(3): 326-330.
  • 9DAVIS M E, ZUCKERMAN J E, CHOI C H, et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles [J]. Nature, 2010, 464(7291): 1067-1070.
  • 10ALVAREZ-ERVITI L, SEOW Y, YIN H, et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes [J]. Nat Biotechnol, 2011, 29(4): 341-345.

共引文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部